EE621 Cost-Effectiveness Analysis of iGlarLixi Compared With Basal Bolus Insulin Regimen in Triple Metabolic Goal in Type 2 Diabetes Mellitus in Latin America
Abstract
Authors
S. Londono W. Garcia C. Salamanca L. Silva V. Santos A. Upegui